- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Results
11
11 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$6.6b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$7.84
7D
-8.3%
1Y
-8.6%
Tong Ren Tang Technologies
Market Cap: HK$5.0b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.03
7D
-5.2%
1Y
-20.0%
Consun Pharmaceutical Group
Market Cap: HK$13.4b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.27
7D
-4.8%
1Y
83.8%
Essex Bio-Technology
Market Cap: HK$2.0b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.66
7D
-4.2%
1Y
29.3%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.2b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.64
7D
-1.6%
1Y
16.3%
CSPC Pharmaceutical Group
Market Cap: HK$94.6b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.33
7D
-8.6%
1Y
77.2%
Shanghai Haohai Biological Technology
Market Cap: HK$8.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$23.06
7D
-4.4%
1Y
-15.1%
China Shineway Pharmaceutical Group
Market Cap: HK$6.5b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.79
7D
-4.0%
1Y
3.8%
Pak Fah Yeow International
Market Cap: HK$732.4m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.35
7D
0.9%
1Y
9.8%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.12
7D
-0.9%
1Y
-8.2%
Jacobson Pharma
Market Cap: HK$2.4b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.22
7D
-2.4%
1Y
6.1%